Dale N. Gerding

49.0k total citations · 14 hit papers
329 papers, 33.7k citations indexed

About

Dale N. Gerding is a scholar working on Infectious Diseases, Epidemiology and Critical Care and Intensive Care Medicine. According to data from OpenAlex, Dale N. Gerding has authored 329 papers receiving a total of 33.7k indexed citations (citations by other indexed papers that have themselves been cited), including 258 papers in Infectious Diseases, 173 papers in Epidemiology and 51 papers in Critical Care and Intensive Care Medicine. Recurrent topics in Dale N. Gerding's work include Clostridium difficile and Clostridium perfringens research (232 papers), Microscopic Colitis (152 papers) and Viral gastroenteritis research and epidemiology (79 papers). Dale N. Gerding is often cited by papers focused on Clostridium difficile and Clostridium perfringens research (232 papers), Microscopic Colitis (152 papers) and Viral gastroenteritis research and epidemiology (79 papers). Dale N. Gerding collaborates with scholars based in United States, United Kingdom and Canada. Dale N. Gerding's co-authors include Stuart Johnson, L. Clifford McDonald, Mark H. Wilcox, Lance R. Peterson, Ciarán P. Kelly, Susan P. Sambol, Robert C. Owens, Vivian G. Loo, Maja Rupnik and Stuart H. Cohen and has published in prestigious journals such as Nature, New England Journal of Medicine and The Lancet.

In The Last Decade

Dale N. Gerding

329 papers receiving 32.2k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America Guidelines for Developing an Institutional Program to Enhance Antimicrobial Stewardship

2006 2.5k citations Dale N. Gerding et al. Clinical Infectious Diseases profile →
Clinical Practice Guidelines for Clostridium difficile Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA)

2010 2.3k citations Dale N. Gerding, Stuart Johnson et al. Infection Control and Hospital Epidemiology profile →
Burden of Clostridium difficile Infection in the United States

2015 2.0k citations Yi Mu, Wendy Bamberg et al. profile →
Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)

2017 1.9k citations L. Clifford McDonald, Dale N. Gerding et al. Clinical Infectious Diseases profile →
An Epidemic, Toxin Gene–Variant Strain of Clostridium difficile

2005 1.6k citations L. Clifford McDonald, Susan P. Sambol et al. profile →
Clostridium difficile infection: new developments in epidemiology and pathogenesis

2009 1.1k citations Mark H. Wilcox, Dale N. Gerding et al. profile →
Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)

2018 787 citations L. Clifford McDonald, Dale N. Gerding et al. Clinical Infectious Diseases profile →
Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: Guidelines for the Prevention of Antimicrobial Resistance in Hospitals

1997 612 citations Dale N. Gerding et al. Clinical Infectious Diseases profile →
Toxin B is essential for virulence of Clostridium difficile

2009 589 citations Susan P. Sambol, Stuart Johnson et al. profile →
Treatment with Monoclonal Antibodies against Clostridium difficile Toxins

2010 557 citations Dale N. Gerding et al. profile →
Trends in U.S. Burden of Clostridioides difficile Infection and Outcomes

2020 529 citations Alice Guh, Yi Mu et al. profile →
Clostridium Difficile-Associated Diarrhea and Colitis

1995 509 citations Dale N. Gerding, Stuart Johnson et al. Infection Control and Hospital Epidemiology profile →
Survival of Influenza Viruses on Environmental Surfaces

1982 407 citations Lance R. Peterson, Dale N. Gerding et al. profile →
Vancomycin, Metronidazole, or Tolevamer for Clostridium difficile Infection: Results From Two Multinational, Randomized, Controlled Trials

2014 394 citations Stuart Johnson, Thomas Louie et al. Clinical Infectious Diseases profile →

Peers

Countries citing papers authored by Dale N. Gerding

Since Specialization

Citations

This map shows the geographic impact of Dale N. Gerding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dale N. Gerding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dale N. Gerding more than expected).

Fields of papers citing papers by Dale N. Gerding

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dale N. Gerding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dale N. Gerding. The network helps show where Dale N. Gerding may publish in the future.

Co-authorship network of co-authors of Dale N. Gerding

This figure shows the co-authorship network connecting the top 25 collaborators of Dale N. Gerding. A scholar is included among the top collaborators of Dale N. Gerding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dale N. Gerding. Dale N. Gerding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Potential underreporting of treated patients using a Clostridioides difficile testing algorithm that screens with a nucleic acid amplification test 2024 ·Infection Control and Hospital Epidemiology ·Alice Guh, Scott K. Fridkin, (unknown), Lisa G. Winston, Helen Johnston, (unknown), Danyel Olson, (unknown), (unknown), (unknown), Dale N. Gerding	4
2	Epidemiology of Clostridioides difficile infection at one hospital 10 years after an outbreak of the epidemic C. difficile strain BI/027: changing strain prevalence, antimicrobial susceptibilities, and patient antibiotic exposures 2024 ·Antimicrobial Agents and Chemotherapy ·(unknown), Andrew M Skinner, Adam Cheknis, (unknown), Vanessa Stevens, Lorinda M. Wright, Dale N. Gerding, Stuart Johnson	2
3	A Randomized Controlled Trial of Efficacy and Safety of Fecal Microbiota Transplant for Preventing Recurrent Clostridioides difficile Infection 2024 ·Clinical Infectious Diseases ·Dimitri Drekonja, Aasma Shaukat, Yuan Huang, Jane H. Zhang, (unknown), Sean Nugent, Jason A. Dominitz, Anne Davis‐Karim, Dale N. Gerding, Tassos C. Kyriakides	13
4	Effective Colonization by Nontoxigenic Clostridioides difficile REA Strain M3 (NTCD-M3) Spores following Treatment with Either Fidaxomicin or Vancomycin 2023 ·Microbiology Spectrum ·Susan P. Sambol, Andrew M Skinner, (unknown), B. J. Owen, Dale N. Gerding, Stuart Johnson	9
5	Treatment of Clostridioides difficile Infection and Non-compliance with Treatment Guidelines in Adults in 10 US Geographical Locations, 2013–2015 2019 ·Journal of General Internal Medicine ·Shannon Novosad, Yi Mu, Lisa G. Winston, Helen Johnston, (unknown), Danyel Olson, Monica M. Farley, (unknown), Lucy Wilson, Rebecca Perlmutter, Stacy Holzbauer, (unknown), Erin C. Phipps, Ghinwa Dumyati, Zintars G. Beldavs, Valerie Ocampo, (unknown), Marion Kainer, Dale N. Gerding, Alice Guh	4
6	Trends in incidence of long-term-care facility onset Clostridium difficile infections in 10 US geographic locations during 2011-2015 2018 ·American Journal of Infection Control ·Alice Guh, Yi Mu, James Baggs, Lisa G. Winston, Wendy Bamberg, Carol Lyons, Monica M. Farley, Lucy Wilson, Stacy Holzbauer, Erin C. Phipps, Zintars G. Beldavs, Marion Kainer, Maria Karlsson, Dale N. Gerding, Ghinwa Dumyati	17
7	Non-toxigenic Clostridioides (Formerly Clostridium) difficile for Prevention of C. difficile Infection: From Bench to Bedside Back to Bench and Back to Bedside 2018 ·Frontiers in Microbiology ·Dale N. Gerding, Susan P. Sambol, Stuart Johnson	37
8	Transmission ofClostridium difficilefrom asymptomatically colonized or infected long-term care facility residents 2018 ·Infection Control and Hospital Epidemiology ·Curtis J. Donskey, Venkata Sunkesula, Nimalie D. Stone, Carolyn V. Gould, L. Clifford McDonald, Matthew H. Samore, Jeanmarie Mayer, (unknown), Annette Jencson, Susan P. Sambol, (unknown), Christopher A. Gulvik, Dale N. Gerding	34
9	Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA) breakdown → 2017 ·Clinical Infectious Diseases ·L. Clifford McDonald, Dale N. Gerding, Stuart Johnson, Johan Bakken, Karen C. Carroll, Susan Coffin, Erik R. Dubberke, Kevin W. Garey, Carolyn V. Gould, Ciarán P. Kelly, Vivian G. Loo, Julia Shaklee Sammons, Thomas J. Sandora, Mark H. Wilcox	1891
10	Comparative Genome Analysis and Global Phylogeny of the Toxin Variant Clostridium difficile PCR Ribotype 017 Reveals the Evolution of Two Independent Sublineages 2016 ·Journal of Clinical Microbiology ·Michelle Cairns, Mark D. Preston, Christopher L. Hall, Dale N. Gerding, Peter M. Hawkey, Hiroo Kato, Heejung Kim, Ed J. Kuijper, Trevor D. Lawley, Hanna Pituch, Siobhán Reid, Brian Kullin, Thomas V. Riley, Katie Solomon, Perng‐Jy Tsai, J. Scott Weese, Richard A. Stabler, Brendan W. Wren	44
11	Vancomycin, Metronidazole, or Tolevamer for Clostridium difficile Infection: Results From Two Multinational, Randomized, Controlled Trials breakdown → 2014 ·Clinical Infectious Diseases ·Stuart Johnson, Thomas Louie, Dale N. Gerding, Oliver A. Cornely, Scott Chasan-Taber, David Fitts, Steven P Gelone, Colin Broom, David M. Davidson, (unknown)	394
12	Strategies to Prevent Clostridium difficile Infections in Acute Care Hospitals: 2014 Update 2014 ·Infection Control and Hospital Epidemiology ·Erik R. Dubberke, Philip Carling, Ruth Carrico, Curtis J. Donskey, Vivian G. Loo, L. Clifford McDonald, Lisa L. Maragakis, Thomas J. Sandora, David J. Weber, Deborah S. Yokoe, Dale N. Gerding	36
13	Clostridium difficile infection rates and spectrum of disease among peripartum women at one hospital from 2003 to 2007 with molecular typing analysis of recovered Clostridium difficile isolates 2010 ·American Journal of Infection Control ·Anilrudh A. Venugopal, Dale N. Gerding, Stuart Johnson	17
14	Molecular Epidemiology ofClostridium difficileover the Course of 10 Years in a Tertiary Care Hospital 2009 ·Clinical Infectious Diseases ·Jaime Belmares, Stuart Johnson, Jorge P. Parada, Mary M. Olson, Connie Clabots, (unknown), Lance R. Peterson, Dale N. Gerding	40
15	Clostridium difficile 30 years on: what has, or has not, changed and why? 2009 ·International Journal of Antimicrobial Agents ·Dale N. Gerding	52
16	Strategies to prevent Clostridium difficile infections in acute care hospitals 2008 ·Digital Commons@Becker (Washington University School of Medicine) ·Erik R. Dubberke, Dale N. Gerding, David C. Classen, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	15
17	A Mouse Model of Clostridium difficile–Associated Disease 2008 ·Gastroenterology ·Xinhua Chen, Kianoosh Katchar, Jeffrey D. Goldsmith, N. Nanda Nanthakumar, Adam Cheknis, Dale N. Gerding, Ciarán P. Kelly	399
18	Clostridium Difficile-Associated Diarrhea and Colitis breakdown → 1995 ·Infection Control and Hospital Epidemiology ·Dale N. Gerding, Stuart Johnson, Lance R. Peterson, Maury E. Mulligan, Joseph Silva	509
19	Nosocomial Clostridium difficile colonisation and disease 1990 ·The Lancet ·(unknown), Stuart Johnson, Connie Clabots, (unknown), Mary M. Olson, Lance R. Peterson, Dale N. Gerding, (unknown), (unknown), Dale N. Gerding	265
20	Tissue Penetration of the New Quinolones in Humans 1989 ·Clinical Infectious Diseases ·Dale N. Gerding, (unknown)	51

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact